Watchlist Price Alert

Apimeds Pharmaceuticals U... (APUS)

NYSE: APUS · Real-Time Price · USD

1.72

0.09 (5.52%)

At close: Jun 23, 2025, 3:51 PM

1.67

-2.91%

After-hours: Jun 23, 2025, 04:00 PM EDT

Apimeds Pharmaceuticals US Inc Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022
Net Income	-311.63K	-332.52K	-449.36K	-296.47K	-566.97K	-110.02K	-36.08K	-64.63K	-74.59K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a	-1	22.44K	47.55K	48.39K
Other Working Capital	175.97K	113.13K	243.19K	6.46K	212.91K	-170.57K	-501	n/a	-2.15K
Other Non-Cash Items	36.05K	32.64K	22.12K	26.91K	13.48K	8.09K	8.25K	8.25K	8.41K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	175.97K	113.13K	243.19K	6.46K	212.91K	-170.57K	-501	n/a	-2.15K
Operating Cash Flow	-99.62K	-186.75K	-184.06K	-263.1K	-340.57K	-272.5K	-5.89K	-8.83K	-19.95K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	150K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	76.5K	n/a	100K	n/a	-555K	1.02M	n/a	9K	282.9K
Financial Cash Flow	76.5K	150K	100K	n/a	n/a	1.02M	n/a	9K	282.9K
Net Cash Flow	-23.12K	-36.76K	-84.06K	-263.1K	-340.57K	750.6K	-5.89K	171.00	262.94K
Free Cash Flow	-99.62K	-186.75K	-184.06K	-263.1K	-340.57K	-272.5K	-5.89K	-8.83K	-19.95K